John Barbieri, MD, MBA, FAAD

Researchers behind the latest benzene studies found no increased cancer risk with use of products containing benzoyl peroxide.

Barbieri spoke with Dermatology Times to discuss the new guidelines and the recommendations and good practice statements included.

John Barbieri, MD, MBA, FAAD, discusses his SDPA Annual Summer Dermatology Conference sessions, "Foundational Tools for Acne and Rosacea Management," and "Neutraceuticals and Cosmeceuticals: Which to Choose?"